Lipofilling for Healing of Chronic Wounds
NCT05509673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2022-08-22
Summary
Chronic wounds remain a therapeutic and financial challenge for physicians and the health care systems. Innovative, cheap and effective treatment methods would be of immense value. The sublesional fat grafting could be such treatment, although the effectiveness and safety have not been assessed in large randomized clinical trials. The aim of this trial was to analyse the effect of adipose tissue on the healing of chronic lower leg wounds. For this purpose, the wounds were surgically cleaned (wound debridement) and then fat was suctioned out from the stomach or thighs and then injected into the edges of the wound and under the wounds. The wounds are covered with a foam dressing that is changed every 3-4 days. There are controls on days 3, 7, 14 and 21 after the intervention and a follow-up examination 2 months after the intervention. The primary objective is the reduction of the wound area 14 days and 2 month after intervention. Secondary objectives are pain level of the wound, bacterial colonialisation of the wound and analysis of the grafted fat tissue (ammount of mesenchymal stem cells)
Conditions
- Wound Healing Disorder
Interventions
- OTHER
-
Lipofilling (sublesional fat grafting)
Sponsors & Collaborators
-
Cologne-Merheim Medical Center (CMMC)
collaborator UNKNOWN -
University of Witten/Herdecke
lead OTHER
Principal Investigators
-
Oliver C Thamm, MD, PhD · University of Witten/Herdecke
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-29
- Primary Completion
- 2016-11-30
- Completion
- 2017-03-06
More Related Trials
-
Mechanisms Underlying Impaired Diabetic Wound Healing
NCT00777712 ·Status: RECRUITING
-
The Difference in Wound Size Reduction Comparing Two Frequently Used Wound Dressings in Everyday Care
NCT03596112 ·Status: COMPLETED ·Phase: NA
-
Local Application of Autologous Bone Marrow Cells for Treatment of Chronic Diabetic Ulcers
NCT00292357 ·Status: UNKNOWN ·Phase: PHASE1
-
A Case Series Evaluating a Collagen Wound Dressing to Treat Wounds
NCT03909503 ·Status: WITHDRAWN ·Phase: NA
-
Developing a Diabetic Foot Ulcer Protocol
NCT01068171 ·Status: WITHDRAWN ·Phase: NA
-
Negative Pressure Wound Therapy in the Management of Diabetic Foot Ulcers
NCT04093635 ·Status: UNKNOWN
-
Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.
NCT01816672 ·Status: TERMINATED ·Phase: NA
-
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
NCT02092870 ·Status: COMPLETED ·Phase: PHASE2
-
Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin
NCT02675335 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effectiveness of the Autologous Adipose Tissue Harvested With SEFFICARE Method for Treatment of DFU Minor Amputation
NCT05072353 ·Status: UNKNOWN ·Phase: NA
-
Randomized Controlled Clinical Investigation Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot Ulcers
NCT05519501 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs
NCT02866565 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Platelet Rich Plasma and Autologous Fat Graft for Diabetic Ulcer
NCT03085550 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
NCT01816633 ·Status: TERMINATED ·Phase: NA
-
Cold atmOspheric plaSMa Therapy Versus standArd Wound Care in Diabetic Foot and Venous Leg ulcerS
NCT07251426 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Allogenic Dermis Versus Standard Care in the Management of Diabetic Foot Ulcers
NCT02331147 ·Status: COMPLETED ·Phase: NA
-
Acellular Dermal Allograft for Chronic Diabetic Wounds
NCT06227520 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers
NCT02248077 ·Status: WITHDRAWN ·Phase: PHASE4
-
Treatment of Diabetic Foot Ulcers With AUP1602-C
NCT04281992 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Platelets for Acute Wound Healing
NCT00125086 ·Status: COMPLETED ·Phase: NA
-
Effect of rhGM-CSF on the Healing of Venous Leg Ulcers
NCT04823962 ·Status: UNKNOWN ·Phase: PHASE2
-
Enhanced Ultrasound Treatment of Chronic Wounds With Monitoring of Healing and Quality of Life Outcomes
NCT03041844 ·Status: UNKNOWN ·Phase: NA
-
Impaired Wound Healing in Diabetic Foot Ulceration
NCT00739323 ·Status: COMPLETED
-
Pathophysiology of Chronic Wounds
NCT00006437 ·Status: COMPLETED
-
Treatment of Diabetic Foot Ulcers With Inforatio Technique to Promote Wound Healing
NCT03985306 ·Status: COMPLETED ·Phase: NA